Clinical trial NCT01351441: Minimizing Risk and Maximizing Outcomes in Geriatric Patients Through Integrated Clinical Pharmacy Services in an Innovative Model of Community Practice
Official title: Minimizing Risk and Maximizing Outcomes in Geriatric Patients Through Integrated Clinical Pharmacy Services in an Innovative Model of Community Practice
Study type: INTERVENTIONAL
Overall status: COMPLETED
Phase: NA
Conditions: Medication Adherence
Health Literacy
Geriatric Patient Care Improvement
Pharmacy Economic Improvement
Keywords: Geriatric
Pharmacoeconomics
Health Literacy
Adherence
Lead sponsor: VascuScript Pharmacy
Sponsor class: OTHER
Collaborators: name: Community Pharmacy Foundation
First posted: 2011-05-10
Enrollment: 20
Sex: ALL
Minimum age (years): 65
Standard ages: OLDER_ADULT
Accepts healthy volunteers: yes
Allocation: NA
Intervention model: SINGLE_GROUP
Primary purpose: HEALTH_SERVICES_RESEARCH

Brief summary: It has been shown that patients can improve their safety through informed choice, safe medication use, and complication reporting. This includes not only the potential problems that occur from prescription medication use but also issues that may arise through the improper use of over-the-counter medications. The willingness of a patient to take on safety action is known to be complicated by an unwillingness to behave in a manner that might challenge a physician's judgment or actions. Community pharmacists are in the unique position to provide perspective on the physician's recommendation and act as an advocate to facilitate necessary change. Through supportive and repeated interaction with their community pharmacist patients will develop assertiveness toward their own health care, an increased frequency and quality of interaction with their physician, and thus a minimized risk of harm and maximized opportunity to optimize clinical outcomes.

Detailed description: This is a single center, observational study to determine if geriatric patients who are on five or more chronic medications will have a difference in clinical, humanistic, and/or economic outcome through an integrated clinical pharmacy service intervention. The primary efficacy objective will be assessed through a single cohort, paired research design measuring the change from baseline in the adherence rate, number of medication related problems, and Beers criteria medications. The primary economic objective will be assessed through prescription revenue to validate the employment of a 0.5-1.0 Full-time equivalent (FTE). Secondary efficacy objectives will be assessed through a single cohort, paired research design measuring the change from baseline in the health literacy, optimization in the anthropometrics, and health related quality of life (HRQOL).

Eligibility criteria: Inclusion Criteria:

* Patients who are at least 65 years of age
* Have at least 5 medications that they take on a chronic basis
* Willing to have their prescriptions filled by VascuScript Pharmacy
* Understand the terms of the informed consent

Exclusion Criteria:

* Any patient who does not meet the requirements of the Inclusion Criteria

Primary outcomes:
measure: Medication adherence
timeFrame: Every 30 days for 12 months
measure: Medication related problems
timeFrame: Every 30 days for 12 months
measure: Beers criteria medications
timeFrame: Every month for 12 months
measure: Economic impact
timeFrame: 12 months
Secondary outcomes:
measure: Health literacy
timeFrame: 12 months
measure: Optimizing Anthropometrics
timeFrame: 12 months
measure: Quality of Life
timeFrame: 12 months
Other outcomes:
Locations:
city: Cheektowaga
country: United States
facility: VascuScript Pharmacy
state: New York
Study officials:
References: